title: Ipilimumab-induced colitis: a rare but serious side effect.
authors: Department of Medicine, University of Missouri School of Medicine, Columbia, Missouri, United States of America.
authors: Alisha M
authors: AM
authors: Hinds
authors: Department of Medicine, University of Missouri School of Medicine, Columbia, Missouri, United States of America.
authors: Dina S
authors: DS
authors: Ahmad
authors: Department of Medicine, University of Missouri School of Medicine, Columbia, Missouri, United States of America.
authors: Joseph E
authors: JE
authors: Muenster
authors: Department of Medicine, University of Missouri School of Medicine, Columbia, Missouri, United States of America.
authors: Zachary M
authors: ZM
authors: Berg
authors: Department of Medicine, University of Missouri School of Medicine, Columbia, Missouri, United States of America.
authors: Kristi T
authors: KT
authors: Lopez
authors: Department of Anatomical Pathology, University of Missouri School of Medicine, Columbia, Missouri, United States of America.
authors: Jason S L
authors: JS
authors: Holly
authors: Department of Medicine, University of Missouri School of Medicine, Columbia, Missouri, United States of America.
authors: Michelle L
authors: ML
authors: Matteson-Kome
authors: Department of Medicine, University of Missouri School of Medicine, Columbia, Missouri, United States of America.
authors: Matthew L
authors: ML
authors: Bechtold
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003092:Colitis / Q000139:chemically induced* / Q000175:diagnosis; D003113:Colonoscopy; D006801:Humans; D000074324:Ipilimumab; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000074324:Ipilimumab